Internal Medicine/Cardiology


Enrique Carbajal, MD

    Associate Clinical Professor of Medicine, UCSF
  Medical School:

University Autonomous of Guadalajara (UAG)/
National University Autonomous of Mexico (UNAM)

  Residency: Texas Tech University, El Paso, Texas
  Fellowship: Cardiovascular Disease, VACCHC System, UCSF Fresno Medical Education Program
  Board Certified:

Internal Medicine


  Awards and Recognition: Tobacco Related Disease Research Program-University of California
  Research: Amlodipine randomized placebo-withdrawal angina and ischemia study Beta-and Calcium Channel blocker Therapy for Myocardial Ischemia in Cigarette Smokers

Evaluation of the incidence and significance of silent myocardial ischemia in patients with coronary artery disease.
  Publications (since 2009):  

Deedwania PC, Carbajal EV. Getting with the ACC/AHA guidelines for the treatment of chronic angina as a disease state. Rev Cardiovasc Med. 10 (Suppl 1): S11-20. 2009

Carbajal EV, Deedwania P. Role of medical versus interventional strategies to prevent coronary events in patients with stable coronary artery disease. Cardiol Clin. 157-65. 2011

Deedwania P, Carbajal E. Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina. Am J Med. 124(8):681-8

Deedwania PC,Carbajal E. Evidence-based therapy for heart failure. Med Clin North Am. 2012 Sep;96(5):915-31




Deedwania P, Nelson J, Carbajal E. Pathophysiology of Myocardial ischemia during hours of sleep: Relationship to determinants of myocardial oxygen demand. Circulation 78;4(suppl II):II-3741988